In the semaglutide group, there was an improvement in quality of life according to the Kansas City Cardiomyopathy Questionnaire (KCCQ-CSS), with a mean change in KCCQ-CSS score of 13.7 points with semaglutide and 6.4 points with placebo (p 1% significantly decreased hospitalisations (aOR 1.33
This groundbreaking treatment has been carefully developed through cutting-edge research and clinical trials, with proven effectiveness in managing blood sugar levels, promoting weight loss, and improving overall quality of life
Reduces risk of cardiovascular diseases With its ability to enhance insulin sensitivity, lower blood glucose levels, and decrease weight, tirzepatide is considered to have the potential to manage cardiovascular diseases, such as hypertension and heart disease
However, their profound impact on metabolic health often comes with a trade-off in the digestive tract
It depends on what peptide and the person
Nourishes and Revitalises: Provides essential nutrients, helping it stay nourished and fresh